On the inhibition of camel retina acetylcholinesterase activity by cycloheximide in vitro

Cell Biology and Toxicology

Volumn 14, Issue 3, 1998, Pages 167-174

  Al Jafari, A A ^a   Kamal, M A ^a   Alhomida, A S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Acetylcholinesterase; Cycloheximide; Inhibition; Kinetics; Retina

Indexed keywords

ACETYLCHOLINESTERASE; CYCLOHEXIMIDE;

ANIMAL TISSUE; ARTICLE; CAMEL; CONTROLLED STUDY; ENZYME INHIBITION; INHIBITION KINETICS; MICHAELIS CONSTANT; NONHUMAN; PRIORITY JOURNAL; RETINA;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; CAMELS; CHOLINESTERASE INHIBITORS; CYCLOHEXIMIDE; MOLECULAR STRUCTURE; RETINA;

EID: 0031777666     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007421124793     Document Type: Article

References (32)

1. Alhomaida AS, Kamal MA, Al-Jafari AA. Evaluation of the nature of camel retinal acetylcholinesterase inhibition by hexamethonium. J Enzyme Inhib. 1998 [In press].
2. Al-Jafari AA. Investigation of the reversible inhibition of camel (Camelus dromedarius) acetylcholinesterase by tetracaine. Comp Biochem Physiol. 1993;105C:323-7.
3. Al-Jafari AA. The nature of the inhibition of camel retina acetylcholinesterase (EC 3.1.1.7) activity by tetrahydroaminoacridine. J Ocular Pharm Ther. 1996;12(4):503-14.
4. Al-Jafari AA. The inhibitory effect of neuromuscular blocking agent gallamine triethioide on camel retina acetylcholinesterase activity. Toxicol Lett. 1997;90(1):45-51.
5. Al-Jafari AA, Kamal MA. The preparation and kinetic properties of multiple forms of chicken brain acetylcholinesterase. Cell Biochem Funct. 1994;12:29-35.
6. Al-Jafari AA, Kamal MA. Effect of tetrahydroaminoacridine on the turnover kinetics of camel (Camelus dromedarius) retina acetylcholinesterase. Biochem Mol Biol Int. 1996;39: 917-22.
7. Al-Jafari AA, Kamal MA, Duhaiman AS, Alhomida AS. Acetylcholinesterase from desert cobra (Walterinessia aegyptid) venom: optimization and kinetics study. Mol Cell Biochem. 1995;151:21-6.
8. Al-Jafari AA, Al-Khwyter F, Kamal MA, Alhomaida AS. Kinetics for camel (Camelus dromedarius) retina acetylcholinesterase inhibition by methotrexate in vitro. Jpn J Pharmacol. 1996;72:49-55.
9. Al-Jafari AA, Al-Khwyter F, Kamal MA. Inhibitory effects of cisplatin: an antineoplastic agent on the activity of acetylcholinesterase in camel retina Cancer Lett. 1998 [In press].
10. Al-Khwyter F, Kamal MA, Al-Jafari AA. The inhibitory effect of cyclophosphamide on camel retina acetylcholinesterase. Toxicol Lett. 1996;87:69-76.
11. Balasubramanian AS, Bhanumathy CD. Noncholinergic functions of cholinesterase. FASEB J. 1993;7:1354-8.
12. Betina V. In: Nauta WTh, Rekker RF, eds. The chemistry and biology of antibiotics. New York: Elsevier; 1983;5:179-526.
13. Cohen SG, Chishti SB, Bell DA, Howard SI, Salih E, Cohen JB. General occurrence of binding to acetylcholinesterase-substrate complex in noncompetitive inhibition and in inhibition by substrate. Biochim Biophys Acta. 1991;1076:112-22.
14. Dixon M. The determination of enzyme inhibitor constant. J Biochem. 1953;55:170-1.
15. Duhaiman AS. Purification and some properties of camel lens crystallins. Curr Eye Res. 1988;7:871-6.
16. Duhaiman AS, Alhomida AS, Rabbani N, Kamal MA, Al-Jafari AA. Purification and characterization of acetylcholinesterase from Desert Cobra (Walterinessia aegyptia) venom. Biochimie. 1996;77:46-50.
17. Ellman HL, Courtney D, Andres V, Featherston RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88-95.
18. Gibbs A, Macdonald PW. Preliminary experiments to determine which host ribosomes are used by some further plant viruses. Intervirology. 1974;4(1):52-6.
19. Hallek M, Szinicz L. Effects of some mono and bisquaternary ammonium compounds on the reactivatability of somaninhibited human acetylcholinesterase in vitro. Biochem Pharmacol. 1988;37:819-25.
20. Jones RA. Evidence for cycloheximide acting as a glutamine analogue in plant tissue. Biochim Biophys Acta. 1977;474 (1):154-61.
21. Leatherbarrow RJ. GraFit. Version 3.0. Staines, UK: Erithacus Software Ltd; 1992.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin Phenol reagent. J Biol Chem. 1953;193:265-75.
23. Moss DE, Fahrney D, Anisomycin, acetylcholinesterase, cycloheximide, and puromycin as inhibitors of rat brain acetylcholinesterase in vitro. J Neurochem. 1976;26:1155-7.
24. Nery-da-Matta AH, Raul F, Torres-da-Matta J, Nesralla-Lobao H, Chagas C. The effect of puromycin, nalidixic acid, and cycloheximide on acetylcholinesterase purified from Electrophorus electricus. C R Acad Sci Hebd Seances Acad Sci D. 1975;281(10):655-8.
25. Neville LF, Gnatt A, Loewenstein Y, Soreq H. Aspartate-70 to glycine substitution confers resistance to naturally occurring and synthetic anionic-site ligands on in-ovo produced human butyrylcholinesterase. J Neurosci Res. 1990;27:452-60.
26. Quinn DM. Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states. Chem Rev. 1987;87: 955-79.
27. Rengstorff R, Royston M. Miotic drugs: a review of ocular, visual, and systemic complications. J Optom Physiol Opt. 1976;53:70-80
28. Small DH. Acetylcholinesterase: zymogens of neuropeptide processing enzymes? Neuroscience. 1989;29:241-9.
29. Segel IH. Behaviour and analysis of rapid equilibrium and steady-state enzyme systems. In: Enzyme kinetics. New York: Wiley; 1975; 170-6.
30. Selitrennikoff CP, Allin D, Sonneborn DR. Chitin biosynthesis during Blastocladiella zoospore germination: evidence that the hexoseamine biosynthesis pathway is post-translationally activated during cell differentiation. Proc Natl Acad Sci USA. 1976;73(2):534-8.
31. Simone C, Derewlany LO, Oskamp M, Johnson D, Knie B, Koren G. Acetylcholinesterase and butyrylcholinesterase activity in the human term placenta: implications for fetal cocaine exposure. J Lab Clin Med. 1994;123(3):400-6.
32. Taylor P, Radic Z. The cholinesterases: from genes to proteins. Annu Rev Pharmacol Toxicol. 1994;34:281-320.